SFS
BCRX icon

Sowell Financial Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Sowell Financial Services’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30,167
Closed -$418K – 196
2021
Q4 		$418K Buy
30,167
+9
+0% +$119 0.02% 454
2021
Q3 		$433K Sell
30,158
-2,227
-7% -$35.1K 0.03% 415
2021
Q2 		$512K Buy
32,385
+7,749
+31% +$105K 0.03% 414
2021
Q1 		$318K Buy
24,636
+12,941
+111% +$133K 0.01% 820
2020
Q4 		$87K Buy
11,695
+3,328
+40% +$17.2K ﹤0.01% 1205
2020
Q3 		$29K Buy
8,367
+7,183
+607% +$30.8K ﹤0.01% 1390
2020
Q2 		$6K Buy
+1,184
New +$4.73K ﹤0.01% 1831

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return